The High Bleeding Risk Patient: An Expert Panel Review

Tuesday, May 21, 2019: 6:45 AM-7:45 AM
Castellana Ballroom 2 (The Cosmopolitan of Las Vegas)

Supported By: Boston Scientific and Medtronic

Sponsored By:

This satellite symposium will include a careful discussion of the findings of all of these trials and how they might best be applied to real world clinical practice. Also, the program will review risk stratification for HBR patients, and use case-based presentations to explore the HBR patient who requires PCI.

The learning objectives for this satellite symposium are as follows:

  • Identify PCI patients at high bleeding risk (HBR) 
  • List strategies to best minimize the risks associated with high bleeding risk
  • Discuss new tools and technologies to optimize outcomes among HBR patients undergoing PCI
Moderator:
Robert W. Yeh, M.D., FSCAI
6:45 AM
Welcome and Introductions
Robert W. Yeh, M.D., FSCAI, Beth Israel Deaconess Medical Center
6:47 AM
Who is the High Bleeding Risk Patient?
Eric Secemsky, M.D., FSCAI, Beth Israel Deaconess Medical Center/Harvard Medical School
6:55 AM
Best Practices for Reducing Procedural Bleeding in the HBR Patient?
Sunil V. Rao, M.D., FSCAI, Duke University Hospital
7:03 AM
Choosing the Optimal Duration of DAPT in High Risk Bleeding Patients: How I Decide?
Rodrigo Bagur, M.D., Ph.D., London Health Sciences Centre
7:11 AM
Discussion
7:17 AM
Optimizing Antithrombotic Selection and Duration in Patients on Oral Anticoagulation
David Lee Fischman, M.D., FSCAI, Jefferson Medical College
7:25 AM
Stent Selection in HBR Patients: Does It Matter? What Is the Evidence?
Robert W. Yeh, M.D., FSCAI, Beth Israel Deaconess Medical Center
7:33 AM
Case Presentation: The Conundrum of High Bleeding and Ischemic Risk
David Lee Fischman, M.D., FSCAI, Jefferson Medical College
7:41 AM
Discussion
See more of: Satellite Sessions
<< Previous Satellite | Next Satellite >>